Search - tctmd.com

Displaying 281 - 300 of 465

Sort: Relevancy | Date

Presentation

Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Effect of Renal Denervation

Presenter: James P. Howard

January 11, 2016

Presentation TCT 2015

Featured Vascular Innovation Technologies 5: Denervation in Hypertensive Renal Transplantation Patients Verves Disruptive Nonvascular Catheter Option to Nephrectomy

Presenter: Greg L. Kaluza, Joachim Schofer, Richard R. Heuser

October 15, 2015

Presentation TCT 2015

TCT 90: Sustained Beneficial Effects of Multielectrode Renal Denervation on Cardiac Adaptations in Resistant Hypertension A 24-Month Follow-up Study

Presenter: Michael A. Weber, Stephen G. Worthley, Konstantinos Tsioufis

October 13, 2015

Presentation TCT 2015

TCT 89: Renal Sympathetic Denervation in Treatment-Resistant Essential Hypertension a Sham-Controlled, Double-blinded Randomized Trial (RESET trial)

Presenter: Michael A. Weber, Stephen G. Worthley, Ole Mathiassen

October 13, 2015

Presentation TCT 2015

TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches

Presenter: Michael A. Weber, Stephen G. Worthley, Tim A. Fischell

October 13, 2015

Presentation TCT 2015

TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results

Presenter: Michael A. Weber, Stephen G. Worthley, Roland E Schmieder

October 13, 2015

Presentation TCT 2015

TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study

Presenter: Michael A. Weber, Stephen G. Worthley

October 13, 2015

Presentation TCT 2015

TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study

Presenter: Michael A. Weber, Stephen G. Worthley, Melvin D. Lobo

October 13, 2015

Presentation TCT 2015

TCT 84: Enhanced Circumferential Ablation Using a Multielectrode Bipolar/Unipolar Over-the-Wire Renal Denervation RF Catheter System With Closed-Loop Sensing

Presenter: Michael A. Weber, Stephen G. Worthley, Elazer R. Edelman

October 13, 2015

Presentation TCT 2015

TCT 83: Long-term (24-Month) Blood Pressure Results of Catheter-Based Renal Artery Denervation SYMPLICITY HTN-3 Randomized Controlled Trial

Presenter: Michael A. Weber, Stephen G. Worthley, Deepak L. Bhatt

October 13, 2015

Presentation TCT 2015

Guidewire-Based Autonomic Neural Sensing From the Artery Lumen: Applications in Renal Denervation, Cancer, and Dysautonomias (Autonomix)

Presenter: Robert S. Schwartz

October 13, 2015

Presentation TCT 2015

Rox: Percutaneous Fistula Creation

Presenter: C. Venkata S. Ram, Krishna J. Rocha-Singh, Thomas Zeller

October 11, 2015

Presentation TCT 2015

Mobius HD: A Self-Expanding Carotid Implant

Presenter: C. Venkata S. Ram, Krishna J. Rocha-Singh, Thomas Zeller, Farrell O. Mendelsohn

October 11, 2015

Presentation TCT 2015

Baroreceptor Stimulation: CVRx and Beyond

Presenter: C. Venkata S. Ram, Krishna J. Rocha-Singh, Thomas Zeller, Atul Pathak

October 11, 2015

Presentation TCT 2015

Ablative Solutions (Chemical Neurolysis)

Presenter: C. Venkata S. Ram, Krishna J. Rocha-Singh, Thomas Zeller, Wojtek Wojakowski

October 11, 2015

Presentation TCT 2015

Nonvascular Renal Denervation (Verve)

Presenter: C. Venkata S. Ram, Krishna J. Rocha-Singh, Thomas Zeller, Richard R. Heuser

October 11, 2015

Presentation TCT 2015

From SYMPLICITY HTN-3 to Ongoing Renal Denervation Studies: What Answers Can We Expect (and Not Expect) From the Ongoing RDN Studies?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane

October 11, 2015

Presentation TCT 2015

Denervx Microwave for Denervation

Presenter: C. Venkata S. Ram, Krishna J. Rocha-Singh, Thomas Zeller, Stefan C. Bertog

October 11, 2015

Presentation TCT 2015

Kona Noninvasive Therapy System

Presenter: C. Venkata S. Ram, Krishna J. Rocha-Singh, Thomas Zeller, Roland E Schmieder

October 11, 2015

Presentation TCT 2015

Keynote Lecture: If I Had Uncontrolled Hypertension

Presenter: Farrell O. Mendelsohn, William B. White, Horst Sievert

October 11, 2015

Advertisement

Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Effect of Renal Denervation

Featured Vascular Innovation Technologies 5: Denervation in Hypertensive Renal Transplantation Patients Verves Disruptive Nonvascular Catheter Option to Nephrectomy

TCT 90: Sustained Beneficial Effects of Multielectrode Renal Denervation on Cardiac Adaptations in Resistant Hypertension A 24-Month Follow-up Study

TCT 89: Renal Sympathetic Denervation in Treatment-Resistant Essential Hypertension a Sham-Controlled, Double-blinded Randomized Trial (RESET trial)

TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches

TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results

TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study

TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study

TCT 84: Enhanced Circumferential Ablation Using a Multielectrode Bipolar/Unipolar Over-the-Wire Renal Denervation RF Catheter System With Closed-Loop Sensing

TCT 83: Long-term (24-Month) Blood Pressure Results of Catheter-Based Renal Artery Denervation SYMPLICITY HTN-3 Randomized Controlled Trial

Guidewire-Based Autonomic Neural Sensing From the Artery Lumen: Applications in Renal Denervation, Cancer, and Dysautonomias (Autonomix)

Rox: Percutaneous Fistula Creation

Mobius HD: A Self-Expanding Carotid Implant

Baroreceptor Stimulation: CVRx and Beyond

Ablative Solutions (Chemical Neurolysis)

Nonvascular Renal Denervation (Verve)

From SYMPLICITY HTN-3 to Ongoing Renal Denervation Studies: What Answers Can We Expect (and Not Expect) From the Ongoing RDN Studies?

Denervx Microwave for Denervation

Kona Noninvasive Therapy System

Keynote Lecture: If I Had Uncontrolled Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content